ERIS2020-01-012020-03-31in-bse-fin:OneOperatingExpenses01Member ERIS2020-01-012020-03-31in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares ERIS 2019-04-01 2020-03-31 2020-06-23 INR Millions Yearly Single segment Pharmaceutical 2020-01-01 2020-03-31 Audited Consolidated 2485660000.00 -10660000.00 2475000000.00 240180000.00 168370000.00 -37560000.00 556040000.00 3540000.00 143180000.00 786290000.00 1860040000.00 614960000.00 0.00 614960000.00 114840000.00 -62600000.00 52240000.00 0.00 562720000.00 0.00 0.00 0.00 0.00 562720000.00 -6840000.00 555880000.00 0.00 0.00 135780000.00 1 4.13 4.13 0.00 0.00 4.13 4.13 Single segment 2019-04-01 2020-03-31 Audited Consolidated 10740590000.00 153960000.00 10894550000.00 768810000.00 732430000.00 214070000.00 2056930000.00 21620000.00 502580000.00 3284610000.00 7581050000.00 3313500000.00 0.00 3313500000.00 606960000.00 -258530000.00 348430000.00 0.00 2965070000.00 0.00 0.00 0.00 0.00 2965070000.00 -12180000.00 2952890000.00 0.00 0.00 135780000.00 1 12827560000.00 21.61 21.59 0.00 0.00 21.61 21.59 Other Expenses 786290000.00 Other Expenses 3284610000.00